Publications

cd30 expression in de novo diffuse large b-cell lymphoma: a population-based study from british columbia.	diffuse large b-cell lymphoma (dlbcl) is a heterogeneous disease with variable therapeutic responses and alternative therapies are needed for patients with unfavourable treatment outcomes after standard treatment with r-chop (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone). one promising candidate is brentuximab vedotin, an antibody-drug conjugate targeting cd30-expressing cells. however, cd30 (tnfrsf8) expression patterns in dlbcl are not well described thus far. here, we exa ...	2014	25135752
pretreatment assessment and dental management of patients with nasopharyngeal carcinoma.	patients who present with nasopharyngeal carcinoma (npc) require through oral and dental assessment prior to treatment of the malignancy. we assessed the oral status of 57 consecutive patients with a diagnosis of npc. in this study, identified risk factors for npc were seen to be different in asian versus non-asian patients. epstein-barr virus seropositivity was seen in all asian patients and in 69% of non-asian patients (p = 0.00006), and reported alcohol use was greater in the non-asian patien ...	1999	10211308